Allianz Biotechnologie - A - EUR/ DE0008481862 /
| NAV10/4/2024 | Chg.-2.7600 | Type of yield | Investment Focus | Investment company |
|---|---|---|---|---|
| 211.6600EUR | -1.29% | paying dividend | Equity | Allianz Gl.Investors ▶ |
Funds documents
| Date | Document | Year | Language | Filesize |
|---|---|---|---|---|
| 10/6/2024 | Public WebStation Live Factsheet | 2024 | English | - |
| 6/30/2024 | Semi-annual report | 2024 | German | 319.23 KB |
| 5/13/2024 | PRIIP Key Information Document | 2024 | English | 300.46 KB |
| 5/13/2024 | PRIIP Key Information Document | 2024 | German | 264.56 KB |
| 1/15/2024 | Prospectus | 2024 | German | 1,042.62 KB |
| 12/31/2023 | Account statment | 2023 | English | 178.80 KB |
| 12/31/2023 | Account statment | 2023 | German | 214.22 KB |
| 6/30/2023 | Semi-annual report | 2023 | English | 127.19 KB |
| 9/13/2022 | Key Investor Information | 2022 | English | 77.21 KB |
| 9/13/2022 | Key Investor Information | 2022 | German | 77.64 KB |
| 7/25/2022 | Prospectus | 2022 | English | 650.16 KB |
